(TheLibertyRevolution.com)- It was learned last week that Senator Rand Paul’s wife Kelley purchased between $1,001 and $15,000 worth of shares in Gilead, the pharmaceutical company that makes the coronavirus treatment drug Remdesivir. Kelley Paul purchased these stocks back in February 2020 just as the COVID-19 pandemic began raging around the world.
The Senator’s disclosure of the stock purchase came sixteen months after the 45-day deadline required by the 2012 STOCK Act – the legislation created to prevent Congressional insider trading and increase transparency.
Naturally, the least effective legislator in Congress, Representative Alexandria Ocasio-Cortez, had to weigh in on the news. Because sniping at Republicans is what Ocasio-Cortez does instead of legislating.
Taking to Twitter, as she always does, Ocasio-Cortez claimed that it was “absolutely wild” members of Congress are allowed to buy or sell stocks, adding that it should be against the law.
Ocasio-Cortez went on to say that “we” introduced legislation to stop members of Congress from making investments in stocks, but “it’s a very uphill battle to pass.” That’s probably because many of Ocasio-Cortez’s fellow Democrats have gotten fabulously wealthy from investments – including her boss, Speaker Nancy Pelosi.
But unless Kelley Paul has some kind of crystal ball that would have allowed her to know back in February 2020 that Remdesivir would emerge as a possible treatment for COVID, it is unlikely her purchase of Gilead stock had anything to do with trying to profit off of the COVID pandemic.
In fact, according to Senator Paul’s spokesperson Kelsey Cooper, Kelley Paul’s investment in Gilead is worth less money today than it was when she purchased the shares. Gilead was worth $74.70 a share on the day Kelley Paul purchased the stock. By last week, the stock was worth $70.88 a share. Cooper also explained that the Senator had filled out the paperwork within the deadline required, however for some reason, the paperwork had not been filed.
Senator Paul did not disclose that Kelley has sold the stock – meaning she has not realized any firm losses or gains from her February 2020 purchase.